WuHan Hvsen Biotechnology: Investor Relations Activity Schedule for April 25, 2024
Huisheng Biotech: 2023 Independent Director Debriefing Report (Zeng Zhenling)
Huisheng Biotech: Announcement on holding the 2023 online performance briefing
Huisheng Biotech: 2023 Internal Control Self-Evaluation Report
Huisheng Biotech: Verification Opinions of CITIC Construction Investment Securities Co., Ltd. on the 2023 Internal Control Self-Assessment Report of Wuhan Huisheng Biotechnology Co., Ltd.
Huisheng Biotech: Announcement on the 2023 Profit Distribution Plan
Huisheng Biotech: 2023 Supervisory Committee Work Report
Huisheng Biotech: 2023 Annual Audit Report
Huisheng Biotech: CITIC Construction Investment Securities Co., Ltd. special inspection report on the storage and use of funds raised by Wuhan Huisheng Biotechnology Co., Ltd. in 2023
Huisheng Biotech: 2023 Board Work Report
Huisheng Biotech: Special Verification Report on the 2023 Operating Income Deduction Statement of Wuhan Huisheng Biotechnology Co., Ltd.
Huisheng Biotech: Report on the 2023 Assessment of Accounting Firms Performance and the Audit Committee's Performance of Supervisory Duties
Huisheng Biotech: 2023 Annual Report
Huisheng Biotech: 2023 Independent Director Debriefing Report (Xie Huobao)
Huisheng Biotech: CITIC Construction Investment Securities Co., Ltd.'s inspection opinions on Wuhan Huisheng Biotechnology Co., Ltd. and its subsidiaries applying for comprehensive credit lines from financial institutions in 2024 and having actual controllers provide guarantees and related transactions
Huisheng Biotech: Supervisory Board Resolutions Announced
Huisheng Biotech: Announcement on changing the registered capital and amending the “Articles of Association”
Huisheng Biotech: Special Audit Report on the Summary Table of Non-operating Capital Occupation and Other Related Capital Transactions of Wuhan Huisheng Biotechnology Co., Ltd.
Huisheng Biotech: Announcement on the company and its subsidiaries applying for comprehensive credit lines from financial institutions in 2024 and providing guarantees and related transactions by the company's actual controller
Huisheng Biotech: Summary table on the use of non-operating capital and other related capital transactions in 2023
No Data